# Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.

> **NCT00444509** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW685698X
- **DRUG:** GW685698X containing magnesium stearate

## Key facts

- **NCT ID:** NCT00444509
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-17
- **Primary completion:** 2007-04-09
- **Final completion:** 2007-04-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444509, "Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00444509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*